Safety of intramuscular COVID-19 vaccination in patients with haemophilia.

Andreas TiedeHendrik LeiseSilvia HorneffJohannes Oldenburg Susan HalimehChristine HellerChristoph KönigsKatharina HolsteinChristian Pfrepper

Published in: Haemophilia : the official journal of the World Federation of Hemophilia (2022)

This is the first prospective study reporting on the safety of intramuscular vaccination in haemophilia. The rate of injection site bleeding was low in mild haemophilia, and in moderate and severe haemophilia if patients received factor prophylaxis.

Keyphrases

end stage renal disease
coronavirus disease
ejection fraction
sars cov
chronic kidney disease
prognostic factors
peritoneal dialysis
early onset
adverse drug